Improving the quality of anaemia diagnosis

Ambulatory care specialists at BHP founder-member the University of Birmingham, with support from Vifor Pharma UK Limited (VPUK), are working to develop and implement a population based anaemia diagnosis and treatment decision support service for routine healthcare delivery. Anaemia is one of the most common laboratory abnormalities in both community and hospital settings. It is … Continue reading “Improving the quality of anaemia diagnosis”

Complex innovative trials: getting medicines to patients faster

Complex Innovative Design (CID) trials could be transformed for the better, following the publication of recommendations in the British Journal of Cancer. The authors believe, if implemented, the 10 recommendations they’ve developed for CID trials could ultimately reduce the time it takes to get innovative treatments to patients with cancer. They are now calling on … Continue reading “Complex innovative trials: getting medicines to patients faster”

New scan set to help children with brain tumours

Ground-breaking research by BHP members has discovered a new technique to assess how aggressively a child’s brain tumour is likely to develop. Funded by Children with Cancer UK, Action Medical Research and The Brain Tumour Charity, the study is the first of its kind and will allow clinicians to give more personalised treatments for childhood … Continue reading “New scan set to help children with brain tumours”

2019 – a year in review

As 2019 draws to a close, we’re reflecting on a an excellent year of discovery science, UK and world firsts, new treatments for patients, and new partnerships. We’ve been visited by a real-life astronaut, celebrated significant grants from generous charities, and made progress in understanding disease pathology – setting us up for a busy 2020 … Continue reading “2019 – a year in review”

Could AI help develop personalised psychosis therapies?

A new multicentre study will investigate the link between brain inflammation and psychosis, and use artificial intelligence techniques to identify patients that might benefit most from novel treatments. The study, funded by UKRI Medical Research Council, is led by BHP founder member the University of Birmingham, and the University of Cambridge. Researchers will examine how and … Continue reading “Could AI help develop personalised psychosis therapies?”